P626: Anti-TNF monotherapy is associated with an adverse clinical outcome in female Inflammatory Bowel Disease patients who stop Anti-TNF treatment during the third trimester of pregnancy.ECCO'22Year: 2022
Authors: Lastiri, E.(1);Herrera-De Guise, C.(1);Casellas, F.(1);Mayorga, L.(1);Robles, V.(1);Cespedes, E.(1);Perez, Z.(1);Oller, E.(1);Borruel-Sainz, N.(1);
(1)Hospital Universitari Vall D´Hebron, Servei Aparell Digestiu. Unitat D´Atenció Crohn/Colitis, Barcelona, Spain;
P627: Variables associated with evolution to moderate to severe Crohn's disease at two reference centers in Salvador, Bahia, BrazilECCO'22Year: 2022
Authors: Da Silva Beda Sacramento, C.(1);Pamponet Motta, M.(2);Oliveira Alves, C.(2);Araujo Mota, J.(3);Goes de Codes, L.M.(1);Freitas Ferreira, R.(4);de Almeida Silva, P.(4);do Prado Palmiro, L.(4);Miranda Barbosa, R.(4);Nery Andrade, M.(5);Damasceno Andrade, V.(5);Brandão Vasconcelos, V.(5);Wasconcellos Thiara, B.(6);Martins Netto, E.(7);Oliveira Santana, G.(7);
(1)Universidade Federal da Bahia - Hospital Universitário Professor Edgard Santos, Programa de Pós Graduação em Medicina e Saúde, Salvador, Brazil;(2)Universidade Federal da Bahia - Hospital Universitário Professor Edgard Santos, Gastroenterology, Salvador, Brazil;(3)Hospital Geral Roberto Santos, Gastroenterology, Salvador, Brazil;(4)Universidade Estadual da Bahia, Escola de Medicina, Salvador, Brazil;(5)Escola Bahiana de Medicina e Saúde Pública, Escola de Medicina, Salvador, Brazil;(6)Universidade Salvador, Escola de Medicina, Salvador, Brazil;(7)Universidade Federal da Bahia, Programa de Pós Graduação em Medicina e Saúde, Salvador, Brazil;
P628: Processed and ultra-processed food and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)ECCO'22Year: 2022
Authors: Dong, C.(1,2);Casagrande, C.(3);Chan, S.(4,5);Huybrechts, I.(3);Nicolas, G.(3);Boutron-Ruault, M.C.(2);Carbonnel, F.(1,2);
(1)University Hospital of Bicêtre- Assistance Publique-Hôpitaux de Paris and University Paris-Saclay, Department of Gastroenterology, Le Kremlin Bicêtre, France;(2)Institut Gustave Roussy-University Paris Sud, INSERM- Centre for Research in Epidemiology and Population Health- U1018- Team 9, Villejuif, France;(3)World Health Organization, International Agency for Research on Cancer, Lyon, France;(4)Norfolk and Norwich University Hospital NHS Trust, Department of Gastroenterology, Norwich, United Kingdom;(5)University of East Anglia, Department of Medicine, Norwich, United Kingdom;
P629: Evolution of disease phenotype, time to biological therapy and medium-, long-term surgery rates in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohortECCO'22Year: 2022
Authors: Gonczi, L.(1);Lakatos, L.(2);Golovics, P.(3);Pandur, T.(4);David, G.(2);Erdelyi, Z.(2);Szita, I.(2);LakatosPhD, P.L.(1,5);
(1)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(2)Ferenc Csolnoky Hospital, Department of Gastroenterology, Veszprem, Hungary;(3)Hungarian Defence Forces- Medical Centre, Department of Gastroenterology, Budapest, Hungary;(4)Grof Esterhazy Hospital, Department of Gastroenterology, Papa, Hungary;(5)McGill University Health Centre, Department of Gastroenterology, Montreal, Canada;
P630: Systematic review and meta-analysis: Diagnostic delay and the subsequent impact on the disease course of adult Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Jayasooriya, N.(1,2,3);Ballie , S.(1,2);Blackwell, J.(1,2);Creese, H.(3);Bottle, R.(3);Petersen, I.(4,5);Saxena, S.(3);Pollok, R.C.(1,2,3);
(1)St George’s Healthcare NHS Trust- St George’s University London, Gastroenterology, London, United Kingdom;(2)St George's University, Institute of Infection and Immunity, London, United Kingdom;(3)Imperial College London, School of Public Health, London, United Kingdom;(4)University College London, Department of Primary Care and Population Health, London, United Kingdom;(5)Aarhus University, Department of Clinical Epidemiology, Denmark, Denmark;POP IBD Study Group
P631: Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases. -A nationwide, retrospective study-ECCO'22Year: 2022
Authors: Kutschera, M.(1);Ritschl, V.(2);Berthold, R.(3);Stamm, T.(2);Kiener, H.(4);Maier, H.(5);Reinisch, W.(1);Benka, B.(6);Novacek, G.(1);
(1)Division of Gastroenterology and Hepatology, Department of Internal Medicine III- Medical University of Vienna, Vienna, Austria;(2)Institute of Outcomes Research, Center for Medical Statistics- Informatics and Intelligent Systems- Medical University of Vienna, Vienna, Austria;(3)Austrian Health Insurance Fund, Austrian Health Insurance Fund, Eisenstadt, Austria;(4)Division of Rheumatology, Department of Internal Medicine III- Medical University of Vienna, Vienna, Austria;(5)Department of Dermatology, Department of Dermatology- Medical University of Vienna, Vienna, Austria;(6)Division of Public Health, Austrian Agency for Health and Food Safety Ltd., Vienna, Austria;
P632: Estimating indirect and out-of-pocket disease-associated costs in paediatric Inflammatory Bowel Disease: a nation-wide cross-sectional analysisECCO'22Year: 2022
Authors: El-Matary, W.(1);Witt, J.(2);Bersnstein, C.(3);Jacobson, K.(4);Mack, D.(5);Otley, A.(6);Walters, T.(7);Huynh, H.(8);deBruyn, J.(9);Griffiths, A.(10);Benchimol, E.(10);
(1)University of Manitoba, Department of Paediatric Gastroenterology, Winnipeg, Canada;(2)University of Manitoba, Economics, Winnipeg, Canada;(3)University of Manitoba, Gastroenterology, Winnipeg, Canada;(4)BC Children's Hospital, Paediatric Gastroenterology, Vancouver, Canada;(5)Children's Hospital of Eastern Ontario, CHEO Inflammatory Bowel Disease Centre- Division of Gastroenterology- Hepatology and Nutrition, Ottawa, Canada;(6)Dalhousie University, Paediatric Gastroenterology, Halifax, Canada;(7)Hospital for Sick Children, Gastroenterology, Toronto, Canada;(8)University of Alberta, Paediatric Gastroenterology, Edmonton, Canada;(9)University of Calgary, Gastroenterology- Alberta Children’s Hospital, Calgary, Canada;(10)The Hospital for Sick Children, SickKids Inflammatory Bowel Disease Centre- Division of Gastroenterology- Hepatology and Nutrition, Toronto, Canada;
P635: Incidence, prevalence, disease phenotype and maximal therapeutic step in Ulcerative Colitis patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem County cohortECCO'22Year: 2022
Authors: Lakatos, L.(1);Gonczi, L.(2);Golovics, P.(3);Pandur, T.(4);David, G.(1);Erdelyi, Z.(1);Szita, I.(1);LakatosPhD, P.L.(2,5);
(1)Ferenc Csolnoky Hospital, Department of Gastroenterology, Veszprem, Hungary;(2)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(3)Hungarian Defence Forces- Medical Centre, Department of Gastroenterology, Budapest, Hungary;(4)Grof Esterhazy Hospital, Department of Gastroenterology, Papa, Hungary;(5)McGill University Health Centre, Department of Gastroenterology, Montreal, Canada;
P636: Work disability after 20 years with Inflammatory Bowel Disease - results from the IBSEN studyECCO'22Year: 2022
Authors: Lund, C.(1,2);Kristensen, V.A.(1,3);Monstad, I.L.(3);Solberg, I.C.(1);Hovde, Ø.(4);Huppertz-Hauss, G.(5);Henriksen, M.(6);Høie, O.(7);Bernklev, T.(8);Jahnsen, J.(1,9);Moum, B.(1,2);Høivik, M.L.(1,2);
(1)Oslo University Hospital- Ullevål, Department of Gastroenterology, Oslo, Norway;(2)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(3)Unger-Vetlesens Institute- Lovisenberg Diaconal Hospital, Department of Gastroenterology, Oslo, Norway;(4)Innlandet Hospital Trust, Department of Gastroenterology, Gjøvik, Norway;(5)Telemark Hospital Trust, Department of Gastroenterology, Skien, Norway;(6)Østfold Hospital Trust, Department of Gastroenterology, Grålum, Norway;(7)Hospital of Southern Norway Trust, Department of Gastroenterology, Arendal, Norway;(8)Vestfold Hospital Trust, Research and Development, Tønsberg, Norway;(9)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;
P637: Risks of Development of COVID-19 among Patients with Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Kappelman, M.(1);Zhang, X.(1);Lewis, J.(2);Melmed, G.(3);Siegel, C.(4);Cerciello, E.(5);Dobes, A.(5);Weaver, A.(5);Weisbein, L.(6);Long, M.(7);
(1)University of North Carolina, Division of Pediatric Gastroenterology- Department of Pediatrics, Chapel Hill, United States;(2)University of Pennsylvania, Medicine, Philadelphia, United States;(3)Cedar Sinai, Medicine, Los Angeles, United States;(4)Dartmouth, Medicine, Hanover, United States;(5)Crohn's & Colitis Foundation, Research, New York, United States;(6)University of North Carolina, Gastroenterology, Chapel Hill, United States;(7)University of North Carolina, Medicine, Chapel Hill, United States;
P639: Incidence and disease presentation of inflammatory bowel disease in Denmark: initial findings from a Copenhagen IBD Inception Cohort StudyECCO'22Year: 2022
Authors: Dorn-Rasmussen, M.(1);Attauabi, M.(2);Madsen, G.R.(3);Wewer, A.V.(1);Jansson, S.(1);Knudsen, M.M.(1);Wilkens, R.(3);Ilvemark, J.F.K.F.(2);Bjerrum, J.W.(2);Theede, K.(3);Bendtsen, F.(3);Trine, B.(3);Seidelin, J.B.(2);Burisch, J.M.(3);
(1)Hvidovre Hospital - University of Copenhagen, The Paediatric Department, Hvidovre, Denmark;(2)Herlev University Hospital, Department of Gastroenterology and Hepatology, Herlev, Denmark;(3)Hvidovre Hospital - University of Copenhagen, Gastrounit - Medical division, Hvidovre, Denmark;
P640: Incidence, prevalence, disease phenotype and maximal therapeutic step in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohortECCO'22Year: 2022
Authors: Lakatos, L.(1);Gonczi, L.(2);Golovics, P.(3);Pandur, T.(4);David, G.(1);Erdelyi, Z.(1);Szita, I.(1);LakatosPhD, P.L.(2,5);
(1)Ferenc Csolnoky Hospital, Department of Gastroenterology, Veszprem, Hungary;(2)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(3)Hungarian Defence Forces- Medical Centre, Department of Gastroenterology, Budapest, Hungary;(4)Grof Esterhazy Hospital, Department of Gastroenterology, Papa, Hungary;(5)McGill University Health Centre, Department of Gastroenterology, Montreal, Canada;
P641: Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based surveyECCO'22Year: 2022
Authors: Revés, J.(1);Abreu, B.(1);Chaparro, M.(2);Gisbert, J.P.(2);Mariangela, A.(3);Fiorino, G.(3);Barberio, B.(4);Zingone, F.(4);Pisani, A.(5);Cassar, D.(5);Michalopoulos, G.(6);Mantzaris, G.(7);Mountaki, K.(7);Koutroubakis, I.(8);Karmiris, K.(9);Katsanos, K.(10);Ďuricova, D.(11);Burisch, J.(12);Madsen, G.R.(12);Maaser, C.(13);Naila, A.(14);Orfanoudaki, E.(8);Milivojevic, V.(15);Buisson, A.(16);Avedano, L.(17);Leone, S.(18);Torres, J.(1);Ellul, P.(5);
(1)Hospital Beatriz Ângelo, Gastrenterology Department, Loures, Portugal;(2)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid UAM- and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastrenterology Unit, Madrid, Spain;(3)IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Gastrenterology and Endoscopy, Milan, Italy;(4)University of Padova, Department of Surgery- Oncology and Gastroenterology DiSCOG- Gastroenterology Unit, Padova, Italy;(5)Mater Dei Hospital, Division of Gastrenterology, Msida, Malta;(6)Tzaneion General Hospital of Piraeus, Gastrenterology Department, Piraeus, Greece;(7)Ophthalmiatreion Athinon and Polyclinic Hospitals, Evangelismos, Athens, Greece;(8)University Hospital of Heraklion, Gastrenterology Department, Heraklion, Greece;(9)Venizeleio General Hospital, Gastrenterology Department, Heraklion, Greece;(10)University and Medical School of Ioannina, Gastrenterology Department, Ioannina, Greece;(11)ISCARE, IBD Clinical and Research Centre, Prague, Czech Republic;(12)Hvidovre Hospital- University of Copenhagen, Gastrounit- medical division, Hvidovre, Denmark;(13)Hospital Lüneburg, Gastrenterology Department, Lüneburg, Germany;(14)St Mark's National Bowel Hospital, IBD Department, London, United Kingdom;(15)Clinical center of Serbia- School of Medicine, Clinic for gastroenterology and hepatology, Belgrade, Serbia;(16)Université Clermont Auvergne- Inserm- U1071- M2iSH- USC-INRA 2018 3iHP- CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France;(17)European Federation of Crohn's and Ulcerative Colitis Associations, efcca, Brussels, Belgium;(18)European Federation of Crohn's and Ulcerative Colitis Associations, effca, Brussels, Belgium;
P642: Crossroads of vitamin B6 deficiency and inflammation in inflammatory bowel disease: Preliminary results of a cross-sectional studyECCO'22Year: 2022
Authors: Farrag, K.(1,2);Woldeab, J.(3);Stein, J.M.(1,2,4);Aksan, A.(2,5);
(1)DGD Clinics Sachsenhausen, Department of Gastroenterology and Clinical Nutrition, Frankfurt am Main, Germany;(2)Interdisciplinary Crohn-Colitis Centre Rhein-Main, Clinical Research, Frankfurt am Main, Germany;(3)Goethe University Frankfurt, Medical School, Frankfurt am Main, Germany;(4)Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, Frankfurt am Main, Germany;(5)Justus-Liebig University Giessen, Institute of Nutritional Science, Giessen, Germany;
P644: Impact of Postoperative Treatment with Immunomodulators and Anti-TNFα agents on long-term Reoperation Rate in ileocaecal Crohn’s Disease.ECCO'22Year: 2022
Authors: AratariPhD, A.(1);Scribano, M.L.(2);Baccolini, V.(3);Pugliese, D.(4);De Biasio, F.(1);Verna, S.(2);Morretta, C.(4);Armuzzi, A.(4);Festa, S.(1);Papi, C.(1);
(1)San Filippo Neri Hospital, IBD UNIT- Department of Gastroenterology, Rome, Italy;(2)Azienda Ospedaliera San Camillo Forlanini, Gastroenterology and Endoscopy Unit, Rome, Italy;(3)Sapienza University of Rome, Department of Public Health and Infectious Diseases, Rome, Italy;(4)Internal Medicine and Gastroenterology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
P645: Ileocecal resection in paediatric Crohn’s disease based on the Hungarian Paediatric IBD RegistryECCO'22Year: 2022
Authors: Müller, K.(1,2);Bajzat, D.(1,3);László, S.S.(4); HUPIR Group
(1)Heim Pal National Institute for Pediatrics, Gastroenterology, Budapest, Hungary;(2)Faculty of Medicine- University of Pécs, Institute for Translational Medicine, Pécs, Hungary;(3)Semmelweis University, Institute for Translational Medicine, Budapest, Hungary;(4)University of Debrecen, Pediatrics Clinic, Debrecen, Hungary;
